ArticleThe EPMA journal2025
Development of a predictive framework for ovarian reserve decline based on pelvic microbiota dysbiosis.
Article in The EPMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diminished ovarian reserve (DOR) is increasingly recognized as a multifactorial condition, not solely related to aging. Emerging evidence suggests that environmental and biological factors, including the pelvic microbiota, may influence ovarian function across different age groups. In this study, we examined the association between pelvic microbiota dysbiosis and DOR, with the broader goal of identifying early microbiota-based markers to support predictive diagnosis, preventive strategies, and personalized reproductive care. Methods: Ascitic fluid samples were collected from women with normal ovarian reserve and those diagnosed with DOR. Microbial profiling was performed using 16S ribosomal RNA (rRNA) gene sequencing to compare the composition and diversity of the pelvic microbiota between the two groups. A multivariable predictive model was constructed by combining key microbial genera with clinical indicators such as body mass index (BMI), aiming to support early risk estimation of DOR. Results: Microbial analysis revealed a significantly higher abundance of Conclusions: Women with a BMI ≥ 24.0 face an increased risk of ovarian function decline. If pelvic microbiota profiling further reveals dysbiosis, particularly
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.